Substance / Medication

Dicyclomine

Overview

Active Ingredient
dicyclomine
RxNorm CUI
3361

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Experimental analysis of antimicrobial action of dicyclomine hydrochloride.
Karaka Prithviraj, Kumar Kuppusamy Asok, Basu Laxmi Rani et al. · Biol Pharm Bull · 2004
PMID: 15577222Observational
Thrombosis Secondary to Intravenous Dicyclomine Administration: A Case Report and Literature Review.
Santibañez Melissa, Lounsbury Nicole, Moreno Maricela et al. · J Pharm Pract · 2026
PMID: 40085944Case Report
A First Report of HCTZ and Dicyclomine Induced Uncharacteristic Contraction Alkalosis.
Eid Tony J, Horton Matthew, Hendrix Claire et al. · J Pharm Pract · 2023
PMID: 34670427Case Report
Problematic dicyclomine use: A case report and narrative review.
Singh Virendra Vikram, Gupta Snehil, Sarkar Siddharth et al. · Asian J Psychiatr · 2020
PMID: 31864128Case Report
Probable association of acute pancreatitis with dicyclomine.
Kaako Ahmad · Turk J Gastroenterol · 2019
PMID: 30459133Case ReportFull text (PMC)
Dicyclomine: cause of abnormally decreased gall bladder ejection with sincalide-stimulated hepatobiliary scintigraphy.
Woodard Jesse, Bencherif Badreddine, Clavell Maria et al. · Clin Nucl Med · 2012
PMID: 22157036Case Report
Unintended consequences of medical interventions - A rare case of iatrogenic dicyclomine and paracetamol dependence.
Nazir Deeba, Wani Zaid Ahmad, Raj Rajnish · Indian J Psychiatry · 2025
PMID: 40918015OtherFull text (PMC)
Formulation and Evaluation of Hydroxypropylmethylcellulose-dicyclomine Microsponges for Colon Targeted Drug Delivery: In Vitro and In Vivo Evaluation.
Sher Muhammad, Sarfaraz Rai Muhammad, Iqbal Sadia et al. · Curr Drug Deliv · 2022
PMID: 34353263Preclinical
Investigation of anti-Parkinson activity of dicyclomine.
Sanawar Maham, Saleem Uzma, Anwar Fareeha et al. · Int J Neurosci · 2022
PMID: 32847457Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dicycloverine (substance)
SNOMED CT
372732007
UMLS CUI
C0012125
RxNorm CUI
3361

Clinical Data

This intervention maps to 6 entities in the Ltrl knowledge graph.

1
Conditions
2
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.